Defining the Genomic Landscape of Diffuse Sclerosing Papillary Thyroid Carcinoma: Prognostic Implications of RET Fusions-Reference-Cited by-同舟云学术

Defining the Genomic Landscape of Diffuse Sclerosing Papillary Thyroid Carcinoma: Prognostic Implications of RET Fusions

Published:2024-06-07 Issue:9 Volume:31 Page:5525-5536
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Scholfield Daniel W.,Fitzgerald Conall W. R.,Boe Lillian A.,Eagan Alana,Levyn Helena,Xu Bin,Tuttle R. Michael,Fagin James A.,Shaha Ashok R.,Shah Jatin P.,Wong Richard J.,Patel Snehal G.,Ghossein Ronald,Ganly Ian

Funder

Center for Cancer Research

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1245/s10434-024-15500-9.pdf

Reference43 articles.

1. Scholfield DW, Fitzgerald CW, Alzumaili B, et al. Diffuse sclerosing papillary thyroid carcinoma: clinicopathological characteristics and prognostic implications compared with classic and tall cell papillary thyroid cancer. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13589-y.

2. Kim SY, Shin SJ, Lee DG, et al. Clinicopathological and genetic characteristics of patients of different ages with diffuse sclerosing variant papillary thyroid carcinoma. Cancers Basel. 2023. https://doi.org/10.3390/cancers15123101.

3. Alswailem M, Alghamdi B, Alotaibi A, et al. Molecular genetics of diffuse sclerosing papillary thyroid cancer. J Clin Endocrinol Metab. 2023. https://doi.org/10.1210/clinem/dgad185.

4. Chou A, Qiu MR, Crayton H, Wang B, et al. A detailed histologic and molecular assessment of the diffuse sclerosing variant of papillary thyroid carcinoma. Mod Pathol. 2023. https://doi.org/10.1016/j.modpat.2023.100329.

5. Baloch ZW, Asa SL, Barletta JA, et al. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol. 2022;1:1. https://doi.org/10.1007/s12022-022-09707-3.